Laboratory misdiagnosis of von Willebrand disease in post- menarchal females: A multi- center study
dc.contributor.author | Jaffray, Julie | |
dc.contributor.author | Staber, Janice M. | |
dc.contributor.author | Malvar, Jemily | |
dc.contributor.author | Sidonio, Robert | |
dc.contributor.author | Haley, Kristina M. | |
dc.contributor.author | Stillings, Amy | |
dc.contributor.author | Weyand, Angela | |
dc.contributor.author | Hege, Kerry | |
dc.contributor.author | Jain, Shilpa | |
dc.contributor.author | Gupta, Sweta | |
dc.contributor.author | Agnew, Caroline | |
dc.contributor.author | Wheeler, Allison | |
dc.contributor.author | Pawar, Anjali | |
dc.contributor.author | Sharma, Mukta | |
dc.contributor.author | Chitlur, Meera | |
dc.contributor.author | Oʼbrien, Sarah H. | |
dc.contributor.author | Kouides, Peter | |
dc.date.accessioned | 2020-09-02T15:01:13Z | |
dc.date.available | WITHHELD_13_MONTHS | |
dc.date.available | 2020-09-02T15:01:13Z | |
dc.date.issued | 2020-09 | |
dc.identifier.citation | Jaffray, Julie; Staber, Janice M.; Malvar, Jemily; Sidonio, Robert; Haley, Kristina M.; Stillings, Amy; Weyand, Angela; Hege, Kerry; Jain, Shilpa; Gupta, Sweta; Agnew, Caroline; Wheeler, Allison; Pawar, Anjali; Sharma, Mukta; Chitlur, Meera; Oʼbrien, Sarah H. ; Kouides, Peter (2020). "Laboratory misdiagnosis of von Willebrand disease in post- menarchal females: A multi- center study." American Journal of Hematology 95(9): 1022-1029. | |
dc.identifier.issn | 0361-8609 | |
dc.identifier.issn | 1096-8652 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/156476 | |
dc.description.abstract | Increased awareness of von Willebrand Disease (VWD) has led to more frequent diagnostic laboratory testing, which insurers often dictate be performed at a facility with off- site laboratory processing, instead of a coagulation facility with onsite processing. Off- site processing is more prone to preanalytical variables causing falsely low levels of von Willebrand Factor (VWF) due to the additional transport required. Our aim was to determine the percentage of discordance between off- site and onsite specimen processing for VWD in this multicenter, retrospective study. We enrolled females aged 12 to 50- years who had off- site specimen processing for VWF assays, and repeat testing performed at a consulting institution with onsite coagulation phlebotomy and processing. A total of 263 females from 17 institutions were included in the analysis. There were 251 subjects with both off- site and onsite VWF antigen (VWF:Ag) processing with 96 (38%) being low off- site and 56 (22%) low onsite; 223 subjects had VWF ristocetin co- factor (VWF:RCo), 122 (55%) were low off- site and 71 (32%) were low onsite. Similarly, 229 subjects had a Factor VIII (FVIII) assay, and 67 (29%) were low off- site with less than half, 29 (13%) confirmed low with onsite processing. Higher proportions of patients demonstrated low VWF:Ag, VWF:RCo, and/or FVIII with off- site processing compared to onsite (McNemarʼs test P- value <.0005, for all assays). These results emphasize the need to decrease delays from sample procurement to processing for VWF assays. The VWF assays should ideally be collected and processed at the same site under the guidance of a hematologist. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.title | Laboratory misdiagnosis of von Willebrand disease in post- menarchal females: A multi- center study | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Oncology and Hematology | |
dc.subject.hlbsecondlevel | Molecular, Cellular and Developmental Biology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.subject.hlbtoplevel | Science | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156476/2/ajh25869.pdf | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/156476/1/ajh25869_am.pdf | en_US |
dc.identifier.doi | 10.1002/ajh.25869 | |
dc.identifier.source | American Journal of Hematology | |
dc.identifier.citedreference | Doshi B, Rogers R, Whitworth H, Stabnick E, Britton J, Butler R. Utility of repeat testing in the evaluation for von willebrand disease in pediatric patients. Blood. 2018; 132: 981. | |
dc.identifier.citedreference | de Maat MP, van Schie M, Kluft C, Leebeek FW, Meijer P. Biological variation of hemostasis variables in thrombosis and bleeding: consequences for performance specifications. Clin Chem. 2016; 62 ( 12 ): 1639 - 1646. | |
dc.identifier.citedreference | Werner EJ, Broxson EH, Tucker EL, Giroux DS, Shults J, Abshire TC. Prevalence of von Willebrand disease in children: a multiethnic study. J Pediatr. 1993; 123 ( 6 ): 893 - 898. | |
dc.identifier.citedreference | Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrandʼs disease. Blood. 1987; 69 ( 2 ): 454 - 459. | |
dc.identifier.citedreference | Ragni MV, Bontempo FA, Hassett AC. von Willebrand disease and bleeding in women. Haemophilia. 1999; 5 ( 5 ): 313 - 317. | |
dc.identifier.citedreference | Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet. 1998; 351 ( 9101 ): 485 - 489. | |
dc.identifier.citedreference | Dilley A, Drews C, Miller C, et al. von Willebrand disease and other inherited bleeding disorders in women with diagnosed menorrhagia. Obstet Gynecol. 2001; 97 ( 4 ): 630 - 636. | |
dc.identifier.citedreference | Shankar M, Lee CA, Sabin CA, Economides DL, Kadir RA. von Willebrand disease in women with menorrhagia: a systematic review. BJOG. 2004; 111 ( 7 ): 734 - 740. | |
dc.identifier.citedreference | Kirtava A, Crudder S, Dilley A, Lally C, Evatt B. Trends in clinical management of women with von Willebrand disease: a survey of 75 women enrolled in haemophilia treatment centres in the United States. Haemophilia. 2004; 10 ( 2 ): 158 - 161. | |
dc.identifier.citedreference | Committee on Adolescent Health Care; Committee on Gynecologic Practice. Committee Opinion No.580: von Willebrand disease in women. Obstet Gynecol. 2013; 122 ( 6 ): 1368 - 1373. | |
dc.identifier.citedreference | Screening and management of bleeding disorders in adolescents with heavy menstrual bleeding: ACOG COMMITTEE OPINION SUMMARY, Number 785. Obstet Gynecol. 2019; 134 ( 3 ): 658 - 659. | |
dc.identifier.citedreference | Branchford BR, Di Paola J. Making a diagnosis of VWD. Hematology Am Soc Hematol Educ Program. 2012; 2012: 161 - 167. | |
dc.identifier.citedreference | Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Variations in coagulation factors in women: effects of age, ethnicity, menstrual cycle and combined oral contraceptive. Thromb Haemost. 1999; 82 ( 5 ): 1456 - 1461. | |
dc.identifier.citedreference | Lippi G, Franchini M, Montagnana M, Salvagno GL, Poli G, Guidi GC. Quality and reliability of routine coagulation testing: can we trust that sample? Blood Coagul Fibrinolysis. 2006; 17 ( 7 ): 513 - 519. | |
dc.identifier.citedreference | Favaloro EJ, Lippi G, Adcock DM. Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis? Semin Thromb Hemost. 2008; 34 ( 7 ): 612 - 634. | |
dc.identifier.citedreference | Favaloro EJ, Bonar R, Marsden K. Lower limit of assay sensitivity: an under- recognised and significant problem in von Willebrand disease identification and classification. Clin Lab Sci. 2008; 21 ( 3 ): 178 - 183. | |
dc.identifier.citedreference | Kim YA, Lewandrowski KB, Lucien FA, Van Cott EM. The effects of transport temperature and time on routine and specialized coagulation assays. Blood Coagul Fibrinolysis. 2018; 29 ( 2 ): 184 - 188. | |
dc.identifier.citedreference | Favaloro EJ, Soltani S, McDonald J. Potential laboratory misdiagnosis of hemophilia and von Willebrand disorder owing to cold activation of blood samples for testing. Am J Clin Pathol. 2004; 122 ( 5 ): 686 - 692. | |
dc.identifier.citedreference | Sidonio RF Jr, Smith KJ, Ragni MV. Cost- utility analysis of von Willebrand disease screening in adolescents with menorrhagia. J Pediatr. 2010; 157 ( 3 ): 456 - 460, 460.e1. | |
dc.identifier.citedreference | Stata Statistical Software [Computer Program]. College Station, TX: StataCorp; 2009. | |
dc.identifier.citedreference | Sharma RaH SL. New Advances in the Diagnosis of von Willebrand Disease. Orlando, FL: American Society of Hematology; 2019. | |
dc.identifier.citedreference | Abildgaard CF, Suzuki Z, Harrison J, Jefcoat K, Zimmerman TS. Serial studies in von Willebrandʼs disease: variability versus "variants". Blood. 1980; 56 ( 4 ): 712 - 716. | |
dc.identifier.citedreference | Preston FE, Lippi G, Favaloro EJ, Jayandharan GR, Edison ES, Srivastava A. Quality issues in laboratory haemostasis. Haemophilia. 2010; 16 ( suppl 5 ): 93 - 99. | |
dc.identifier.citedreference | Coyle T, Gopaluni S, Newman N, Hansen J. Milk Box Misdiagnosis of Von Willebrand Disease Is Common. Blood: American Society of Hematology. 2008; 112 ( 11 ): 2266. | |
dc.identifier.citedreference | Quiroga T, Goycoolea M, Panes O, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica. 2007; 92 ( 3 ): 357 - 365. | |
dc.identifier.citedreference | Obaji S, Alikhan R, Rayment R, Carter P, Macartney N, Collins P. Unclassified bleeding disorders: outcome of haemostatic challenges following tranexamic acid and/or desmopressin. Haemophilia. 2016; 22 ( 2 ): 285 - 291. | |
dc.identifier.citedreference | Downes K, Megy K, Duarte D, et al. Diagnostic high- throughput sequencing of 2396 patients with bleeding, thrombotic, and platelet disorders. Blood. 2019; 134 ( 23 ): 2082 - 2091. | |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.